8-K - INTEGRATED BIOPHARMA INC - 8.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001437749-26-012368

Filing Date: 2026-04-15

Accepted: 2026-04-15 15:35:27

Documents: 12

Period of Report: 2026-04-14

Items: Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

INTEGRATED BIOPHARMA INC (Filer) CIK : 0001016504 (see all company filings) EIN. : 222407475 | State of Incorp.: DE | Fiscal Year End: 0630 Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 26863985 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | FORM 8-K | inbp20260415_8k.htm iXBRL | 8-K

2 | XBRL TAXONOMY EXTENSION SCHEMA | inbp-20260414.xsd | EX-101.SCH

3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | inbp-20260414_def.xml | EX-101.DEF

4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | inbp-20260414_lab.xml | EX-101.LAB